Furthermore, increased healthcare expenditure, demand for innovative therapies, growing awareness for early detection and diagnosis, supportive government initiatives and regulatory frameworks, access to expert healthcare professionals and, the proven efficacy and safety of GLP-1 receptor agonists for managing blood sugar and promoting weight loss are the factors fuelling the market dominance of this segment
What should I do after the HCG injection
The data on vitamin C and DNA damage are conflicting and inconsistent
Weeks 1-4 (Starting Dose, Usually 2.5 mg): Primary focus: Assessing tolerance to medication Appetite changes: Many notice reduced hunger, earlier fullness, fewer cravings Gastrointestinal adjustment: Nausea is common, usually mild to moderate Weight loss: Typically 2-5 pounds (combination of water weight and beginning fat loss) Energy: Some feel fatigued, others report increased energy from eating less Weeks 5-8 (First Dose Increase, Usually 5 mg): Appetite suppression: Often becomes more noticeable after a dose increase Side effects: May temporarily worsen for 3-7 days after dose increase, then improve Weight loss: Additional 3-6 pounds (cumulative 5-11 pounds total from start) Clothes: May start noticing fit changes, though not dramatic yet Weeks 9-16 (Second Dose Increase, Usually 7.5 mg): Appetite suppression: Plateaus at a consistent level for most people Weight loss: Additional 5-10 pounds (cumulative 10-20 pounds total) Plateau possibility: Some people hit temporary plateaus around week 12-16 Lifestyle integration: Getting used to smaller portions, less frequent eating Weeks 17-24 (Third Dose Increase to 10-15 mg, If Tolerated): Weight loss: Additional 5-12 pounds (cumulative 15-30 pounds total at 6 months) 6-month checkpoint: For those in the guarantee program, the 10% loss threshold applies here Muscle loss consideration: Without adequate protein (0.8-1g per pound ideal body weight) and resistance exercise, some muscle loss occurs alongside fat loss Months 7-12 (Maintenance Dose Continuation): Weight loss: Additional 10-20 pounds (cumulative 25-50 pounds total at 12 months) Plateau management: Weight loss slows over time, may require calorie/activity adjustments Side effects: Usually well-tolerated by this point, body adapted Habits: Smaller portions feel normal, appetite remains suppressed on medication Months 13-18 (Long-Term Continuation): Weight loss: Slows significantly, may reach a plateau Total cumulative loss: Highly variable (10-25% of starting body weight for responders) Maintenance focus: Shifting from "losing weight" to "maintaining new weight" What Happens When You Stop This is the uncomfortable truth that advertising doesn't emphasize: Weight regain after stopping GLP-1 medications is common
